AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 32065870
Drug: Trigone-sparing BTX-A
RxNorm normalized name: BTX-A
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: Trigone-sparing BTX-A injection template
Trial: 32065870
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (Trigone-including and Trigone-sparing)
Trial: 32955720
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (50,000 IU weekly) plus magnesium (250 mg daily)
Trial: 33218310
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of both CARE-FAM and WEP-CARE interventions
Trial: 34340975
Drug: Intravitreal dexamethasone
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal dexamethasone (DEX-) implant
Trial: 34340975
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (DEX- implant and bevacizumab)
Trial: 32613563
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving only initial periodontal treatment
Trial: 32771983
Drug: Gastrointestinal care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastrointestinal care bundle including individualized dietary counselling weekly and rapid-access investigation and treatment for bowel symptoms.
Trial: 33593767
Drug: Yellow fever,
RxNorm normalized name: Yellow fever, unspecified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yellow fever, oral typhoid, and HPV vaccines
Trial: 33593767
Drug: HPV and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV and tetanus/diphtheria booster vaccine
Trial: 33218522
Drug: Bowen Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bowen Therapy (real therapy)
Trial: 32986891
Drug: Baclofen (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (60 mg/d)
Trial: 33906073
Drug: Policaptil Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Policaptil Gel Retard (PGR), 6 tablets/day
Trial: 33906073
Drug: Metformin, 1500–2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin, 1500–2000 mg/day in two divided doses
Trial: 32840955
Drug: Professionally-based cognitive-behavioral
RxNorm normalized name: Clearskin Professional Daily Correcting
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Professionally-based cognitive-behavioral therapy for insomnia (PCBT-I)
Trial: 32840955
Drug: Video-based cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video-based cognitive-behavioral therapy for insomnia (VCBT-I)
Trial: 32466881
Drug: Drug-Coated Balloon
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-Coated Balloon (DCB) Angioplasty
Trial: 32466881
Drug: Repeat Drug-Eluting
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeat Drug-Eluting Stent (DES) Implantation
Trial: 32967685
Drug: Indacaterol maleate
RxNorm normalized name: Indacaterol Maleate
DrugBank: Indacaterol (DB05039)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indacaterol maleate 150 μg once daily (o.d.)
Trial: 32967685
Drug: Indacaterol acetate
RxNorm normalized name: indacaterol acetate
DrugBank: Indacaterol (DB05039)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indacaterol acetate 150 μg once daily (o.d.)
Trial: 39058968
Drug: Chemotherapy (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (2 cycles)
Trial: 35033182
Drug: Dexamethasone 6
RxNorm normalized name: dexamethasone 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 6 mg
Trial: 32478922
Drug: Garlic supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic supplementation (1,000 mg for 8 weeks)
Trial: 32763217
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg film-coated tablets
Trial: 32763217
Drug: 35 mg
RxNorm normalized name: papain 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 mg film-coated tablets
Trial: 32763217
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg film-coated tablets or 30 mg dispersible tablets
Trial: 32763217
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg dispersible tablets or 50 mg film-coated tablets
Trial: 35963559
Drug: combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: combined treatment and guanfacine
Trial: 33452967
Drug: Curcuma longa
RxNorm normalized name: Curcuma Longa
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcuma longa (1000 mg/day)
Trial: 33452967
Drug: Miconia albicans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miconia albicans (1000 mg/day)
Trial: 616849227
Drug: Medcall lenses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medcall lenses (ML)
Trial: 37349841
Drug: Pregabalin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (all doses)
Trial: 33441315
Drug: Non-operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-operative treatment pathway (broad-spectrum antibiotics and active observation)
Trial: 33292009
Drug: CPAP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPAP therapy (initially implemented)
Trial: 32783238
Drug: High-proanthocyanidin cranberry
RxNorm normalized name: grape seed proanthocyanidins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-proanthocyanidin cranberry juice (44 mg proanthocyanidin/240-mL serving) consumed twice daily for 8 weeks
Trial: 34890567
Drug: Intensive high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive high-dose adalimumab plus thiopurine (160 mg adalimumab once per week for 4 weeks followed by 40 mg every 2 weeks, with escalation of dose at 4 months and 8 months if needed; initial dose of azathioprine 2·5 mg/kg or mercaptopurine 1·5 mg/kg)
Trial: 34890567
Drug: Standard adalimumab
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Standard adalimumab monotherapy (160 mg at week 0, 80 mg at week 2, then 40 mg every 2 weeks)
Trial: 34890567
Drug: Intensive high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive high-dose adalimumab plus thiopurine
Trial: 34890567
Drug: Standard adalimumab
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Standard adalimumab monotherapy
Trial: 35638317
Drug: Duloxetine (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (maximum 60 mg/daily for 18 weeks)
Trial: 33514390
Drug: Antenatal plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal plasma CMV-DNAemia of > 50 copies/mL
Trial: 33514390
Drug: HIV-infected but
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV-infected but non-transmitting mothers with CMV-DNAemia of > 50 copies/mL
Trial: 32831069
Drug: Benznidazole 30d/150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benznidazole 30d/150 mg
Trial: 32831069
Drug: Benznidazole 60d/300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benznidazole 60d/300 mg
Trial: 33865303
Drug: 5% urea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% urea cream
Trial: 32787905
Drug: TCM formulae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCM formulae (Tiaogan‐BuXu‐Jiedu granules) plus ETV 0.5 mg per day for 96 weeks
Trial: 32787905
Drug: TCM granule
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TCM granule placebo plus ETV 0.5 mg per day for 96 weeks
Trial: 34784719
Drug: Functional broth
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional broth (CF) enriched with 5.6 g FOS/100 g
Trial: 34784719
Drug: Control broth
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control broth (CC) with 0.4 g maltodextrin/100 g
Trial: 32817358
Drug: Lacosamide (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacosamide (up to 12 mg/kg/day or 400 mg/day)
Trial: 34161883
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy (ET) with letrozole+ribociclib
Trial: 32683215
Drug: Constraint Induced
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constraint Induced Movement Therapy (CIMT)
Trial: 33569865
Drug: MLV‐RAL 0.05%/0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MLV‐RAL 0.05%/0.1% cream
Trial: 33569865
Drug: Retinol 0.05%/0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retinol 0.05%/0.1% cream
Trial: 34980827
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of an oxygen-enriched oil-based gel, applied 3 times daily for 10 days
Trial: 32101996
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy (IT)
Trial: 36106379
Drug: Adjunctive perampanel
RxNorm normalized name: Perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Adjunctive perampanel (≤8mg/day)
Trial: 32022887
Drug: Pasireotide, 900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide, 900 μg, subcutaneously twice a day for 7 days
Trial: 32022887
Drug: Hydrocortisone, 100
RxNorm normalized name: Hydrocortisone, 100 mg/60 mL rectal enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone, 100 mg, intravenously 3 times a day for 3 days
Trial: 34282693
Drug: Antibiotic administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotic administration during resuscitation
Trial: 32525465
Drug: Viral load
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viral load <200 copies/mL
Trial: 35008040
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation (AS) with 1000 IU·d‐1 natural vitamin E and 1000 mg·d‐1 vitamin C
Trial: 34085467
Drug: Combination group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination group (EA + acupoint catgut embedding)
Trial: 34419090
Drug: Oropharyngeal administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oropharyngeal administration of colostrum (0.4 ml every 3 hours for 10 days within the first 48 hours after birth)
Trial: 34259920
Drug: Azithromycin suspension
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin suspension administered twice daily by gargling for 30 seconds and swallowing, starting on the first day of chemotherapy.
Trial: 34711335
Drug: Paclitaxel drug-coated
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel drug-coated devices (DCDs)
Trial: 34862643
Drug: Low-Intensity Focused
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Intensity Focused Ultrasound (LIFU) treatment, power output 2.5 W/cm2, frequency 1 MHz, treating time 20 minutes
Trial: 34862643
Drug: Low-Intensity Focused
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Intensity Focused Ultrasound (LIFU) treatment
Trial: 34796837
Drug: Methotrexate combined
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate combined with anti-IL6 receptor (tocilizumab)
Trial: 32053133
Drug: 3 months
RxNorm normalized name: TABLET, DOSE PACK, 3 MONTHS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 months of FOLFOX or CAPOX chemotherapy
Trial: 32053133
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months of FOLFOX or CAPOX chemotherapy
Trial: 32053133
Drug: FOLFOX chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOLFOX chemotherapy (3 months)
Trial: 32053133
Drug: CAPOX chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAPOX chemotherapy (3 months)
Trial: 32053133
Drug: 3 months
RxNorm normalized name: TABLET, DOSE PACK, 3 MONTHS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 months of chemotherapy
Trial: 35762428
Drug: Kindergarten mode
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kindergarten mode treatment (test group)
Trial: 34581765
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (20 μg/d)
Trial: 34581765
Drug: High-protein (HP)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-protein (HP) yogurt (10 g protein/100 g)
Trial: 34581765
Drug: Normal-protein (NP)
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal-protein (NP) yogurt (3.5 g protein/100 g)
Trial: 32816787
Drug: Unguided corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unguided corticosteroid injection
Trial: 32687296
Drug: Electroneurostimulation (ENS)
RxNorm normalized name: Salazopyrin EN
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electroneurostimulation (ENS) of the cervical sympathetic ganglia combined with gymnastics of the oculomotor muscles and shoulder girdle (MG)
Trial: 35854327
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) taken daily until birth
Trial: 35854327
Drug: Metformin taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin taken daily until birth
Trial: 32483622
Drug: Medium-dose D1
RxNorm normalized name: PHOSPHOLIPASE D1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose D1 activation (combination of levodopa and a D2 antagonist)
Trial: 32483622
Drug: Low-dose D1
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose D1 activation
Trial: 32483622
Drug: High-dose D1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose D1 activation
Trial: 35192440
Drug: Client-centered occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Client-centered occupational therapy
Trial: 35192440
Drug: General occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General occupational therapy
Trial: 33591929
Drug: Psychological interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychological interventions alongside analgesics or anesthetics
Trial: 33248590
Drug: Chitosan oligosaccharides
RxNorm normalized name: chitosan oligosaccharide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chitosan oligosaccharides (COS) supplementation at 200 mg/kg
Trial: 35296254
Drug: Multiple medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple medications
Trial: 33082712
Drug: Positive drugs
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive drugs
Trial: 35313268
Drug: 1.5 ml
RxNorm normalized name: Humulin 70/30 1.5 ML Pen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 ml ropivacaine
Trial: 33443859
Drug: Control (tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (tablets devoid of any scent)
Trial: 34337074
Drug: Antibiotic-loaded bone
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic-loaded bone cement repair
Trial: 34337074
Drug: Conventional vacuum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional vacuum sealing draining treatment
Trial: 35168586
Drug: Education program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education program with peer support on social media (Facebook Page of Antibiotic Use), 2 weekly sessions of 90 minutes each.
Trial: 35168586
Drug: Education program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education program with peer support on social media (Facebook Page of Antibiotic Use).
Trial: 35841016
Drug: 3% hydrogen
RxNorm normalized name: HYDROGEN PEROXIDE 30 mg in 1 mL TOPICAL LIQUID [3% Hydrogen Peroxide]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% hydrogen peroxide solution
Trial: 36368248
Drug: Wormwood vaginal
RxNorm normalized name: Wormwood
DrugBank: Wormwood (DB14291)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wormwood vaginal gel
Trial: 35366528
Drug: tACS-30 (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tACS-30 (30 min/2 mA daily sessions for 3 days)
Trial: 33496330
Drug: Child Development
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Child Development Agents (CDA)
Trial: 35338534
Drug: 1-week massed
RxNorm normalized name: Xenon, isotope of mass 129
DrugBank: Xenon Xe-129 (DB17386)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-week massed cognitive processing therapy (CPT) delivered virtually, twice per day for 5 days
Trial: 35193056
Drug: Voucher redemption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voucher redemption or prescription for eyeglasses to be purchased on the market
Trial: 35970918
Drug: 5.45% sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.45% sodium chloride solution (group B)
Trial: 35970918
Drug: 10% sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% sodium chloride solution (group C)
Trial: 35970918
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride solution (group A)
Trial: 35713110
Drug: 10-week internet-based
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-week internet-based cognitive-behavioral therapy (iCBT), n = 26
Trial: 32164507
Drug: 177Lu-PSMA-radioligand therapy
RxNorm normalized name: 177Lu-PSMA-617
DrugBank: Lutetium Lu-177 vipivotide tetraxetan (DB16778)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 177Lu-PSMA-radioligand therapy
Trial: 36368169
Drug: Telerehabilitation (TR)
RxNorm normalized name: hyoscyamine sulfate Extended Release Oral Tablet [Hyoscyamine TR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telerehabilitation (TR) group received real-time motor-cognitive dual-task exercise treatment via video conferencing for 6 weeks
Trial: 37659673
Drug: Guselkumab 200
RxNorm normalized name: guselkumab 200 MG in 20 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guselkumab 200 mg
Trial: 35134323
Drug: Guselkumab 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guselkumab 600 mg
Trial: 35134323
Drug: Guselkumab 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guselkumab 1200 mg
Trial: 32221178
Drug: Antidepressive medications
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressive medications plus cognitive behavioral therapy
Trial: 32221178
Drug: Antidepressive medications
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressive medications plus dynamic psychotherapy
Trial: 32221178
Drug: Antidepressive medications
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressive medications plus psychotherapy (both types)
Trial: 34190962
Drug: Zuranolone, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zuranolone, 30 mg, administered orally each evening for 2 weeks
Trial: 34190962
Drug: Zuranolone, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zuranolone, 30 mg
Trial: 36424687
Drug: Placebo (identical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical glucose tablets)
Trial: 34690065
Drug: Spironolactone 25
RxNorm normalized name: spironolactone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 25 mg daily for 3 months
Trial: 36347450
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea (GT) supplementation (738 mg)
Trial: 33025645
Drug: 6-mm implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-mm implants
Trial: 33025645
Drug: 11-mm implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11-mm implants
Trial: 34538253
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (individual occupational therapy)
Trial: 32853384
Drug: Lattice radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lattice radiation therapy (LRT) with a dose of 24 Gy in three fractions, followed by conventionally fractionated external beam irradiation to 44.28 Gy
Trial: 33338415
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (1000 mg) administered via intramuscular injection at baseline, 6 weeks, and then every 3 months for 2 years.